Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of MMP-9/NGAL Ratio in Diabetic Patients With Early Renal Dysfunction by Piper Crocatum Functional Foods

NCT06676124 is registered in ClinicalTrials.gov with Hasanuddin University as lead sponsor.

NCT NCT06676124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of MMP-9/NGAL Ratio in Diabetic Patients With Early Renal Dysfunction by Piper Crocatum Functional Foods
Lead sponsor
Hasanuddin University
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2024
Completion date
September 16, 2024
Enrollment
387 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy, early renal dysfunction in diabetes, inflammation and oxidative stress in diabetic patients